Navigation Links
Bill Gates to Fund ￡28m for Malaria researc

Bill Gates is to fund ￡28m for research in United Kingdom as part of ￡145m package for research programs worldwide for the eradication of Malaria worldwide. Bill Gates along with his Melinda Gates Foundation is going to sponsor three // international projects for malaria eradication over the next five years. Mr. Gates expressed that more research funding is contributed to research of AIDS and cancer, while malaria, which kills millions of children worldwide, has become a forgotten epidemic. He is confident that if we could expand malaria control programs, and invest what's needed in research and development, we can stop this tragedy.

Liverpool School Project:

Liverpool's Innovative Vector Control Consortium (IVCC) Project is granted to the Liverpool School of Tropical Medicine that will be funded to work on projects that will look at ways to control the mosquitoes that spread malaria by developing safer, more effective, and longer-lasting insecticides for mosquito control. It will also develop improved bed nets and other insecticide-treated materials, and help health authorities determine how to deploy insecticides and bed nets for maximum impact.

Malaria Vaccine Initiative (MVI) Project:

The MVI project will receive a grant of ￡60.4m for conducting clinical trial of newly developed Malarial vaccine by GlaxoSmithKline in Mozambique, Africa. The newly developed vaccine is found to protect young children’s from Malaria infection. The vaccine gives protection in 58% of children’s. The grant will help in doing further clinical trials in 10,000 children and check that the vaccine is safe when given with other childhood vaccines, it can be introduced into Africa's immunisation programme by around 2011.

Medicines for Malaria Venture (MMV) Project:

Medicines for Malaria Venture (MMV) will be receiving a grant ￡56.1m for developing new malaria drugs. The project would aim at producing a
'"/>




Page: 1 2

Related medicine news :

1. Bill Gates Takes Personal Interest in AIDS Program
2. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
3. Gates Foundation to donate USD 104 million to TB Alliance
4. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Gates Foundation Adopts Fight against Encephalitis
7. Clinton, Gates Highlight Treatment, Discrimination of AIDS
8. $68 million aid pours in from Gates Foundation to fight tropical diseases
9. Gates Foundation Grants $23mn for AIDS programme in India
10. Bill Gates pours in funds for diarrhea treatment reseach
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bill Gates Fund for Malaria researc

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
...nce,Commissioner Joel Ario today announced that th...ublic informational hearings across the state to,h...t how the proposed,consolidation of Highmark Inc. ...n Harrisburg,and July 15 in Philadelphia. Each inf...
...cted Officials Not to Privatize,Veterans, Health C...of Government Employees today launched a nationwid...l, mandatory funding for the Department of,Veteran...file veteran and a ranking member of the,Senate Ar...
...ch . , Montreal, May 12, 2008 Losing a limb can...tional and physical pain can linger for years. To ...imb syndrome, Universit de Montral graduate studen...es retain the memory of pain after losing a limb, ...
... cancers that affect tissues such as muscle, fat, ...n Milan, Italy on 13-14 May to discuss the latest ...ntial new avenues for therapy. , The 2nd Symposiu...netics of sarcomas, on understanding how drug resi...
...d to have committed patent and ...12 Mannatech,Incorporated (Nasdaq: MTEX ) a lead...and skin care solutions, today announced that a fe...ademark relating to Ambrotose(R)., The jury found...
... consumers on indoor air quality, ANN ARBOR, Mich... the Environmental Protection Agency (EPA), and DU...unity to educate consumers on the,importance of cl...0, and according to the American Lung Association,...
Other Medicine News:Health News:Insurance Department to Hold Statewide Meetings on Proposed Consolidation of Independence Blue Cross, Highmark 2Health News:AFGE Launches Nationwide Ad Campaign Aimed at Funding the VA 2Health News:2nd ESMO symposium on soft tissue carcinomas and GIST 2Health News:2nd ESMO symposium on soft tissue carcinomas and GIST 3Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 2Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 3Health News:Asthma Awareness Month Spawns Healthy Advice 2
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9PDL BioPharma to Present at BioCentury Newsmakers Conference on September 16 2009 56592 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 2
...ith the continued aging of,the population and the ...f,the disease is crucial for risk assessment, test... with better drugs, once they are developed.,Four ...ion,s 2008,International Conference on Alzheimer,s... that goal of early detection by describing advanc...
...29 Bladder problems may,leave a mark on the brain...,contributing to disrupted sleep and problems with...active bladder, the involuntary bladder contractio...te, such mind-body,connections may be of more than...ust one organ, but here we see how an,abnormal org...
Other Medicine Technology:Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 2Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 3Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 4Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 5Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 6Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 7Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 8Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention 2
...G-9200 is a Windows 2000 PC based EEG with high pe... and software. EEG-9200 provides high quality perf...in the sleep lab or EEG lab. Quality EEG recording...CU. Neurofax has high performance, high sensitivit...
...act is the first magnetic stimulator to offer the ... stimulation. It is designed to provide the simple...tic routine (at the same time, it may also help re...ons without moving away from your patient). , ,...
Fidelity IAB Intra-Aortic Balloon Catheter
...series is a new top-line range of digital pacemake...rillation (AF). Because the T-series combines digi...reatment of AF is taken one step further. Thanks t...ored continuously and extensively. This gives phys...
Medicine Products: